HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FTLD Patient-Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62.

Abstract
Frontotemporal lobar degeneration (FTLD) is a clinically, genetically, and neuropathologically heterogeneous group of neurodegenerative syndromes, leading to progressive cognitive dysfunction and frontal and temporal atrophy. C9orf72 hexanucleotide repeat expansion (C9-HRE) is the most common genetic cause of FTLD, but pathogenic mechanisms underlying FTLD are not fully understood. Here, we compared cellular features and functional properties, especially related to protein degradation pathways and mitochondrial function, of FTLD patient-derived skin fibroblasts from C9-HRE carriers and non-carriers and healthy donors. Fibroblasts from C9-HRE carriers were found to produce RNA foci, but no dipeptide repeat proteins, and they showed unchanged levels of C9orf72 mRNA transcripts. The main protein degradation pathways, the ubiquitin-proteasome system and autophagy, did not show alterations between the fibroblasts from C9-HRE-carrying and non-carrying FTLD patients and compared to healthy controls. An increase in the number and size of p62-positive puncta was evident in fibroblasts from both C9-HRE carriers and non-carriers. In addition, several parameters of mitochondrial function, namely, basal and maximal respiration and respiration linked to ATP production, were significantly reduced in the FTLD patient-derived fibroblasts from both C9-HRE carriers and non-carriers. Our findings suggest that FTLD patient-derived fibroblasts, regardless of whether they carry the C9-HRE expansion, show unchanged proteasomal and autophagic function, but significantly impaired mitochondrial function and increased accumulation of p62 when compared to control fibroblasts. These findings suggest the possibility of utilizing FTLD patient-derived fibroblasts as a platform for biomarker discovery and testing of drugs targeted to specific cellular functions, such as mitochondrial respiration.
AuthorsStina Leskelä, Dorit Hoffmann, Hannah Rostalski, Nadine Huber, Rebekka Wittrahm, Päivi Hartikainen, Ville Korhonen, Ville Leinonen, Mikko Hiltunen, Eino Solje, Anne M Remes, Annakaisa Haapasalo
JournalMolecular neurobiology (Mol Neurobiol) Vol. 58 Issue 11 Pg. 5438-5458 (Nov 2021) ISSN: 1559-1182 [Electronic] United States
PMID34328616 (Publication Type: Journal Article)
Copyright© 2021. The Author(s).
Chemical References
  • C9orf72 Protein
  • C9orf72 protein, human
  • DNA-Binding Proteins
  • Nerve Tissue Proteins
  • SQSTM1 protein, human
  • Sequestosome-1 Protein
  • TARDBP protein, human
  • Proteasome Endopeptidase Complex
Topics
  • Autophagy
  • C9orf72 Protein (biosynthesis, genetics)
  • Cells, Cultured
  • DNA Repeat Expansion
  • DNA-Binding Proteins (metabolism)
  • Fibroblasts (metabolism)
  • Frontotemporal Lobar Degeneration (metabolism, pathology)
  • Heterozygote
  • Humans
  • Mitochondria (physiology)
  • Nerve Tissue Proteins (biosynthesis, genetics)
  • Oxygen Consumption
  • Phosphorylation
  • Proteasome Endopeptidase Complex (metabolism)
  • Protein Processing, Post-Translational
  • Protein Transport
  • Proteolysis
  • Sequestosome-1 Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: